Piracétam : Risque hémorragique = Piracetam: hemorrhage riskLa Revue Prescrire. 2005, Vol 25, Num 257, issn 0247-7750, p. 23Article

New methods for determination of cinnarizine in mixture with piracetam by spectrodensitometry, spectrophotometry, and liquid chromatographyMETWALLY, Fadia H; ELZEANY, B. A; DARWISH, H. W et al.Journal of AOAC International. 2005, Vol 88, Num 6, pp 1666-1676, issn 1060-3271, 11 p.Article

ETUDE CLINIQUE CONCERNANT LE PIRACETAMMARTIN C; SOBOTKA F; CHAZOT G et al.1973; LYON MED.; FR.; DA. 1973; VOL. 229; NO 5; PP. 525-527Serial Issue

Simultaneous Determination of Piracetam and Vincamine by Spectrophotometric and High-Performance Liquid Chromatographic MethodsSHAKER, Yasser; EL-SAHARTY, Ibrahim.Journal of AOAC International. 2008, Vol 91, Num 2, pp 311-321, issn 1060-3271, 11 p.Article

Effect of Position Isomerism on the Formation and Physicochemical Properties of Pharmaceutical Co-CrystalsXIANGMIN LIAO; GAUTAM, Mohan; GRILL, Andreas et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 1, pp 246-254, issn 0022-3549, 9 p.Article

Advances in Pharmaceutical Co-crystal Screening: Effective Cocrystal Screening through Structural ResemblanceSPRINGUEL, Géraldine; NORBERG, Bernadette; ROBEYNS, Koen et al.Crystal growth & design. 2012, Vol 12, Num 1, pp 475-484, issn 1528-7483, 10 p.Article

The effect of piracetam on ataxia : clinical observations in a group of autosomal dominant cerebellar ataxia patientsGUNAL, D. Ince; AGAN, K; AFSAR, N et al.Journal of clinical pharmacy and therapeutics (Print). 2008, Vol 33, Num 2, pp 175-178, issn 0269-4727, 4 p.Article

THE EFFECT OF PIRACETAM (NOOTROPIL, UCB-6215) UPON THE LATE SYMPTOMS OF PATIENTS WITH HEAD INJURIES.AANTAA F; MEURMAN OH.1975; J. INTERNATION. MED. RES.; G.B.; DA. 1975; VOL. 3; NO 5; PP. 352-355; BIBL. 7 REF.Article

Piracetam and levetiracetam : close structural similarities but different pharmacological and clinical profilesGENTON, P; VAN VLEYMENT, B.Epileptic disorders. 2000, Vol 2, Num 2, pp 99-105, issn 1294-9361Article

Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spellsSAWIRES, Happy; BOTROUS, Osama.European journal of pediatrics. 2012, Vol 171, Num 7, pp 1063-1067, issn 0340-6199, 5 p.Article

Effect of Systemic Piracetam Treatment on Flap Survival and Vascular Endothelial Growth Factor Expression after Ischemia-Reperfusion InjuryTUNCER, Serhan; AYHAN, Suhan; FINDIKCIOGLU, Kemal et al.Journal of reconstructive microsurgery. 2011, Vol 27, Num 7, pp 409-417, issn 0743-684X, 9 p.Article

Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological testsCHATTERJIE, Nithiananda; ALEXANDER, George; HSIN WANG et al.Neurochemical research. 2001, Vol 26, Num 10, pp 1171-1176, issn 0364-3190Article

ESPERIENZE CLINICHE CON IL PIRACETAM NEL RISVEGLIO POSTANESTETICO. = EXPERIMENTATION CLINIQUE DU PIRACETAM DANS LE REVEIL POSTANESTHESIQUELA MANNA V; FACCENDINI A; CHIANCA E et al.1976; ACTA ANAESTHESIOL. ITAL.; ITAL.; DA. 1976; VOL. 27; NO 6; PP. 937-944; ABS. ANGL.; BIBL. 18 REF.Article

ETUDE CLINIQUE DU PIRACETAM EN NEUROPSYCHIATRIE INFANTILEBOUCHARLAT J; RATEL M.1973; LYON MED.; FR.; DA. 1973; VOL. 229; NO 4; PP. 417-420Serial Issue

CHLORPROMAZINE, PIRACETAM ET METABOLISME DES PHOSPHOLIPIDES DU CERVEAU CHEZ LE RATROCHUS L; REUSE JJ.1972; C.R. SOC. BIOL.; FR.; DA. 1972; VOL. 166; NO 6-7; PP. 975-978; BIBL. 7 REF.Serial Issue

Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsyKHANI, Yahya Agha; ANDERMANN, Frederick; ANDERMANN, Eva et al.Epilepsia (Copenhagen). 2005, Vol 46, Num 7, pp 1145-1146, issn 0013-9580, 2 p.Article

Suppression of myoclonus in SCA2 by piracetamDE ROSA, Anna; STRIANO, Pasquale; BARBIERI, Fabrizio et al.Movement disorders. 2006, Vol 21, Num 1, pp 116-118, issn 0885-3185, 3 p.Article

VORLAEUFIGE ERFAHRUNGEN MIT PIRACETAM IN DER INTENSIVTHERAPIE SCHWERER SCHAEDEL-HIRN-VERLETZUNGEN = EXPERIENCES PRELIMINAIRES DU PIRACETAME DANS LES SOINS INTENSIFS DES TRAUMATISMES CRANIOENCEPHALIQUES GRAVESSCHULTE AM ESCH J; PFEIFER G.1974; MED. KLIN.; DTSCH.; DA. 1974; VOL. 69; NO 28-29; PP. 1235-1238; ABS. ANGL.; BIBL. 13REF.Article

EXPERIMENTATION CLINIQUE DU PIRACETAMDUBOIS B; FONTAINE G.1973; LILLE MED.; FR.; DA. 1973; VOL. 18; NO 7 SUPPL.; PP. 832-835Article

SUB-OPTIMAL VIGILANCE IN PATIENTS WITH COMPLETE HEART BLOCK: INFLUENCE OF CARDIAC PACING AND A "NOOTROPIC" SUBSTANCEGHONEIM MM; NEWALDT SP; PETERSEN RC et al.1981; PROG. NEURO-PSYCHOPHARMACOL.; ISSN 0364-7722; USA; DA. 1981; VOL. 5; NO 4; PP. 403-409Article

VALIDITA DI UN NUOVO TRATTAMENTO MEDICO DELLA VESCICA NEUROGENA: IL PIRACETAM = VALEUR D'UN NOUVEAU TRAITEMENT DE LA VESSIE NEUROGENE: LE PYRACETAMMORELLI A; BOSSI L.1974; MINERVA UROL.; ITAL.; DA. 1974; VOL. 26; NO 4; PP. 176-181; ABS. ANGL.; BIBL. 1P.Article

EFFECTS OF PIRACETAM (SKF 38462) ON ACQUISITION, RETENTION, AND ACTIVITY IN THE GOLDFISH = EFFETS DU PIRACETAM (SKF 38462) SUR L'ACQUISITION, LA RETENTION ET L'ACTIVITE DU CYPRIN DOREBRYANT RC; PETTY F; BYRNE WL et al.1973; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1973; VOL. 29; NO 2; PP. 121-130; BIBL. 1 P.Serial Issue

EXPERIMENTATION CLINIQUE CHEZ L'ENFANT DU PIRACETAMVIALATTE J.1973; VIE MED.; FR.; DA. 1973; VOL. 54; NO 2; PP. 2327-2330 (4 P.)Serial Issue

EFFET THERAPEUTIQUE DU PIRACETAM DANS UN CAS DE MYOCLONIES D'ACTION POSTANOXIQUE.TERWINGHE G; DAUMERIE J; NICAISE C et al.1978; ACTA NEUROL. BELG.; BELG.; DA. 1978; VOL. 78; NO 1; PP. 30-36; ABS. ANGL.; BIBL. 20 REF.Article

KLINISCHE PRUEFUNG VON 2-PYRROLIDON-ACETAMID (GENERIC NAME PIRACETAM). EINE PILOT STUDY = ETUDE CLINIQUE DE L'ACETAMIDE PYRROLIDONE-2 (PIRACETAM). UNE ETUDE PILOTETACKE B; FREISTEIN H; KEMPF H et al.1975; PHARMAKOPSYCHIATR. NEURO-PSYCHOPHARMAKOL.; DTSCH.; DA. 1975; VOL. 8; NO 2; PP. 82-89; ABS. ANGL.; BIBL. 17REF.Article